AstraZeneca Acquires TeneoTwo in US$1.27 B Deal
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 7 (Table of Contents)
Published: 7 Jul-2022
DOI: 10.3833/pdr.v2022.i7.2702 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to strengthen its haematological oncology pipeline, AstraZeneca has agreed to acquire TeneoTwo, a biotech focused on bispecific antibody therapies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS